Document is current
Any future updates will be listed below
-
Authors
Kuzu, Omer Faruk
Bolek, Hatice
Sertesen Camoz, Elif
Karakas, Hilal
Sekmek, Serhat
Sim, Saadet
Isık, Selver
Günaltılı, Murat
Akkus, Aysun Fatma
Tural, Deniz
Arslan, Cagatay
Goksu, Sema Sezin
Sever, Ozlem Nuray
Karacin, Cengiz
Sendur, Mehmet Ali Nahit
Karadurmus, Nuri
Yekedüz, Emre
Ürün, Yüksel https://orcid.org/0000-0002-9152-9887
- License Information
-
More Information
Article History
Received: 27 April 2025
Accepted: 9 July 2025
First Online: 25 July 2025
Declarations
:
: The study was approved by the Ankara University Faculty Ethics Committee (date:11/09/2024, approval number I09-701–24) and it was carried out in accordance with the Code of Ethics of the World Medical Association also known as a declaration of Helsinki. Due to the retrospective nature of the study the use of anonymized data, no informed consent was required as per the ethics committee approval.
: Not applicable.
: Yüksel Ürün: Advisory work —Abdi-İbrahim, Astellas, AstraZeneca, Bristol Myers-Squibb, Deva, Eczacıbaşı, Gen ilaç, Gilead, GSK, Janssen, Merck, MSD, Novartis, Pfizer, Roche; travel, honoraria and consultation fees—Abdi-İbrahim, Astellas, Bristol Myers-Squibb, Deva, Eczacıbaşı, Gen ilaç, Gilead, GSK, Janssen, Merck, Novartis, Pfizer, Roche.All remaining authors have declared no conflicts of interest.
